• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
EMD 1.96% 5.0¢

EMYRIA LIMITED

Emyria Limited is an Australia-based clinical services and drug development company. The... Emyria Limited is an Australia-based clinical services and drug development company. The Company is focused on developing patient outcomes in neuroscience and mental health through its clinical service delivery, proprietary real-world data (RWD), and drug discovery & development. It delivers evidence-based and emerging therapies for mental health and other unmet needs through its Emerald Clinics and the Pax Centre. Emerald Clinics specializes in providing treatments for patients with complex and chronic conditions. The Pax Centre specializes in treating individuals grappling with the psychological impacts of traumatic experiences. Through its advanced data platform operated by Palantir, the Company collects robust and ethically sourced real-world data to improve its care models and support its distinct therapy and drug development initiatives. The Company is also developing several proprietary ultra-pure cannabinoid dose forms and advancing them towards registration, such as EMD-RX5.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
EMD 14:07 13 860
14:07 Last post  FiSaver Comments Created with Sketch.  13  Views Created with Sketch.  860 
EMD
CEO Podcast
23/04/24 1 335
23/04/24 Last post  gavint66 Comments Created with Sketch.  1  Views Created with Sketch.  335 
EMD
News: EMD Emyria Receives Bids Of A$2.3M To Expand Clinical Services
23/04/24 0 101
TRENDING NEWS

Hillcrest's ZVS Technology Gains Traction in New Applications, Fuels Growth

NEWS
26 Apr 2024
23/04/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  101 
EMD 23/04/24 0 146
23/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  146 
EMD 23/04/24 0 212
23/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  212 
EMD 22/04/24 15 3.5K
22/04/24 Last post  FiSaver Comments Created with Sketch.  15  Views Created with Sketch.  3.5K 
EMD
News: EMD Emyria Seeks Trading Halt
19/04/24 0 122
19/04/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  122 
EMD 10/04/24 3 1.2K
10/04/24 Last post  mc3456 Comments Created with Sketch.  3  Views Created with Sketch.  1.2K 

See All Discussions arrow Created with Sketch.

Timeline

March 2024 Quarterly Activities Report and Appendix 4C
26 Apr 08:40
 
Proposed issue of securities - EMD
23 Apr 09:54
 
Emyria Receives Bids of $2.3M to Expand Clinical Services
23 Apr 09:53
 
Trading Halt
19 Apr 09:14
 
Emyria Opens Empax Centre to Advance Mental Health Care
10 Apr 08:23
 
Emyria Expands Specialist AP Team - First Female for MDMA-AT
05 Apr 08:25
 
View More arrow Created with Sketch.
(20min delay)
Last
5.0¢
Change
-0.001(1.96%)
Mkt cap ! $18.33M
Open High Low Value Volume
5.2¢ 5.2¢ 5.0¢ $11.25K 223.7K

Buyers (Bids)

No. Vol. Price($)
1 11000 4.9¢
 

Sellers (Offers)

Price($) Vol. No.
5.1¢ 66360 1
View Market Depth
Last trade - 13.06pm 26/04/2024 (20 minute delay) ?
Last
5.0¢
  Change
-0.001 ( 0.00 %)
Open High Low Volume
5.2¢ 5.2¢ 5.0¢ 27831
Last updated 12.57pm 26/04/2024 ?
EMD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.